Product Information
GS INFANT PAIN-FEVER 160 MG/5 is a generic product labeled by L. Perrigo Company, priced at $0.0838 per ML under NDC 00113094610. Its NADAC has been published 367 times since Jul 10, 2019.
Strength
160 mg/5mL
Manufacturer
L. Perrigo CompanyNDC
00113094610
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
7/23/2025
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
11/8/2011
Price Statistics
The NADAC for GS INFANT PAIN-FEVER 160 MG/5 has been published 367 times since Jul 10, 2019, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0838 per ML |
|---|---|
| All-time high | $0.1105 (Apr 15, 2020) |
| All-time low | $0.0805 (Feb 17, 2021) |
| 52-week high | $0.0838 |
| 52-week low | $0.0838 |
| Median price | $0.0967 |
| Average price | $0.0954 |
| Largest weekly change | +25.7% (Mar 17, 2021) |
| Weeks tracked | 367 |
| Tracking since | Jul 10, 2019 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
-18.6%
5Y
-11.9%
All
-14.5%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS INFANT PAIN-FEVER 160 MG/5?
The current National Average Drug Acquisition Cost (NADAC) for GS INFANT PAIN-FEVER 160 MG/5, manufactured by L. Perrigo Company, is $0.0838 per ML (NDC 00113094610), effective Jul 15, 2026.
How has the price of GS INFANT PAIN-FEVER 160 MG/5 changed over time?
Over the history we have for it, the NADAC for GS INFANT PAIN-FEVER 160 MG/5 has declined 14.5%. It has been tracked across 367 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for GS INFANT PAIN-FEVER 160 MG/5?
Since Jul 10, 2019, the NADAC for GS INFANT PAIN-FEVER 160 MG/5 has ranged from a low of $0.0805 (Feb 17, 2021) to a high of $0.1105 (Apr 15, 2020), with a median of $0.0967 per ML.
Are there cheaper alternatives to GS INFANT PAIN-FEVER 160 MG/5?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0205 per ML — about 75% below GS INFANT PAIN-FEVER 160 MG/5.
Who manufactures GS INFANT PAIN-FEVER 160 MG/5?
GS INFANT PAIN-FEVER 160 MG/5 (NDC 00113094610) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.